SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000891293-17-000066
Filing Date
2017-06-16
Accepted
2017-06-16 16:44:35
Documents
1
Period of Report
2017-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A a8-kare2017sayonpayvote.htm 8-K/A 26018
  Complete submission text file 0000891293-17-000066.txt   27198
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-28386 | Film No.: 17916603
SIC: 2834 Pharmaceutical Preparations